Australia's Orthocell gets Chinese patent for scaffold technology

Singapore: Australia's regenerative medicine company, Orthocell, has recieved Chinese patent for its Collagen Scaffold f...

January 16, 2015 | Friday | News
SII seeks WHO consent to export flu vaccines

Singapore: Serum Institute of India (SII) has applied for permits to export flu vaccines produced using Australia's BioD...

December 12, 2012 | Wednesday | News
QRxPharma refiles Moxduo NDA with FDA

Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...

November 26, 2013 | Tuesday | News
Japan's NEC to exploit Prima BioMed's cancer immunotherapeutic technology

The press release indicated that Immutep is a French company and is a 100 percent subsidiary of Prima BioMed. Immutep de...

May 12, 2015 | Tuesday | News
Phosphagenics to start opioid pain patch study

Singapore: Melbourne-based Phosphagenics has resolved all crystallisation issues associated with its opioid patch devel...

December 3, 2012 | Monday | News
Australia to finalize a policy on naming biosimilars

Singapore: In July 2013, Therapeutics Goods Administration, Australia, had published a guidance on biosimlar naming base...

January 22, 2015 | Thursday | News
Novotech expands in Asia

Singapore: Australia based Novotech has strengthened its Hong Kong operation with expansion of its manpower base. The c...

January 16, 2015 | Friday | News
Bridge to the DNA vaccine dream

Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appe...

June 6, 2012 | Wednesday | News
AirStrip enters the Australian market

Singapore: US-based AirStrip recently inked a pact with Life Monitor, a subsidiary of Cardioscan, to sell AirStrip solut...

February 19, 2015 | Thursday | News
No vaccination, No benefits, says Australian PM

Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children m...

April 21, 2015 | Tuesday | News
Vaxxas' Nanopatch is the future of needle-free vaccine

One of the challenges in the R&D of next generation vaccines is the development of a delivery technology that will b...

October 17, 2012 | Wednesday | Influencers
The unconventional side of vaccines

When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in rece...

July 23, 2012 | Monday | Opinion
Viralytics melanoma trial meets primary endpoint

Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...

September 18, 2013 | Wednesday | News
QRxPharma, Paladin sign $25.5 mn morphine deal

Singapore: Australia's QRxPharma has collaborated with Canadian specialty pharmaceutical company, Paladin Labs on licens...

October 10, 2012 | Wednesday | News
BioAsia 2014: Innovation, collaboration identified as success keys

Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...

March 5, 2014 | Wednesday | Analysis
Gilead commercial operations head to retire

Singapore: Gilead Sciences' head of commercial operations for the past decade, Mr Kevin Young, who oversaw tremendous sa...

January 8, 2014 | Wednesday | News
Ebola: Australia pledges $17m for treatment centre

Singapore: Australian Prime Minister Mr Tony Abbott said that the nation is contracting a private company to staff and o...

November 6, 2014 | Thursday | News
URMC launches new heart device trial in Asia

Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...

August 7, 2013 | Wednesday | News